Lorcaserin Moves Closer to Approval
Arena Pharmaceuticals is almost doubling after a Food & Drug Administration advisory panel voted to approve the company's lorcaserin weight-loss medicine. ARNA is up 95 percent before the bell on my tradeMONSTER platform.
JPMorgan Loss Another Headwind For Banks
JPMorgan Chase disclosed it had a $2 billion trading loss on a position intended to limit credit losses. It may face another $1 billion of red ink, and the news is hanging over financials across the board. JPM is down more than 8 percent in early trading.
Nvidia Revenue Beats Expectations
Nvidia's first-quarter earnings were in line with forecasts, but revenue was strong at $924.9 million. Analysts had expected $916.7 million. For the second quarter, management sees revenue of $990 million to $1.05 billion, also ahead of the $976.2 million consensus number. NVDA climbs 7 percent before the bell.
Career Education Still Losing Students
Career Education's earnings and revenue were both ahead of Street forecasts. But enrollment dropped 27 percent as the company continues to bleed students. CECO is lower by 7 percent in premarket trading.
Options Trading News
ARNA:
SEE CHART
GET CHAIN
FIND STRATEGIES
Social Media
Follow optionMONSTER for news and updates
Premium Services
-
Semi-active traders looking for simple calls and spreads (5 per week).
Learn More -
Entry-to-mid level traders looking for full circle trade analysis (1 per week).
Learn More -
Tailored, one-on-one education designed and led by Jon & Pete (3 months and up)
Learn More
Education & Strategy
Why education is key to options
People get into option trading for a number of reasons, but there are three primary motivations: to increase income, to...
